Paper Details

  1. Home
  2. Paper Details

Trimethobenzamide HCl in the treatment of nausea and vomiting associated with antineoplastic chemotherapy.

Author: EshelmanF N, HurleyJ D

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

Trimethobenzamide was effective in controlling nausea and vomiting in patients undergoing chemotherapy. Trimethobenzamide was significantly better than placebo in relieving periodic and total nausea. No side effects were recorded.
Paper Details　
Original Abstract of the Article :
Fifty-five patients undergoing chemotherapy for various neoplastic processes were treated with trimethobenzamide or placebo to control nausea and vomiting. Trimethobenzamide was shown to be significantly better than placebo in relieving periodic and total nausea over the 48-hour study. Vomiting inci...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1177/009127008002000508

データ提供：米国国立医学図書館（NLM）

Taming the Nausea and Vomiting Desert: Trimethobenzamide's Role in Chemotherapy

Antineoplastic chemotherapy, a powerful weapon in the fight against cancer, can sometimes leave patients feeling like they are navigating a desert of nausea and vomiting. This research investigates the effectiveness of trimethobenzamide in controlling these debilitating side effects of chemotherapy. The researchers conducted a controlled study, comparing trimethobenzamide to a placebo. Their findings demonstrate that trimethobenzamide significantly reduced both periodic and total nausea, offering hope for patients struggling with this common side effect of cancer treatment.

Trimethobenzamide: A Potential Oasis for Chemotherapy Side Effects

The study reveals that trimethobenzamide effectively reduced nausea and vomiting in patients undergoing chemotherapy, offering a potential solution for mitigating this challenging side effect. While further research is needed to explore the optimal dosage and duration of treatment, these findings suggest that trimethobenzamide could play a valuable role in improving the quality of life for patients undergoing cancer treatment.

Finding Relief in the Chemotherapy Desert

If you are undergoing chemotherapy, discussing your concerns about nausea and vomiting with your healthcare provider is crucial. They can assess your individual needs and recommend the most appropriate treatment approach, including medications like trimethobenzamide. Remember, there are ways to manage these side effects and find relief in the chemotherapy desert.

Dr.Camel's Conclusion

This research offers a promising oasis in the desert of chemotherapy side effects, highlighting the potential of trimethobenzamide to reduce nausea and vomiting. It underscores the importance of open communication with your healthcare provider to explore available options for managing these challenging side effects. Remember, seeking support and guidance can help you navigate this challenging journey.

Date :
  1. Date Completed 1980-10-21
  2. Date Revised 2019-08-25
Further Info :

Pubmed ID

7400373

DOI: Digital Object Identifier

10.1177/009127008002000508

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.